Navigation Links
Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
Date:3/10/2010

REDWOOD CITY, Calif., March 10 /PRNewswire/ -- Codexis, Inc. today announced that Vonnie Estes has joined the company as Vice President, Strategic Planning, Technology.  In this new position, Ms. Estes will be responsible for moving Codexis' technical developments to commercial applications.  She will report to David Anton, Ph.D., Senior Vice President, Research and Development.

Ms. Estes brings Codexis two decades of experience leading product and commercial development programs for global chemical companies, most recently focusing on biofuels. She joins Codexis from DuPont Danisco Cellulosic Ethanol, where she was Vice President, Commercial Development. Previously, she was New Venture Manager, Cellulosic Biofuels for DuPont Advanced Biofuels, where she helped create the commercialization strategy for the DuPont cellulosic ethanol technology.  She also held business development management positions at various companies including Monsanto and Syngenta.  Ms. Estes holds a Bachelor of Science degree from the University of New Mexico and a Master of Science degree in plant pathology from the University of California, Davis.

"Vonnie Estes is a talented and experienced professional with a proven track record in successful development and commercialization of new technology," Dr. Anton said.  "She combines experience from major global corporations and entrepreneurial startups, and will play an important role in commercialization of our technical portfolio and strategy.  We are delighted to welcome her to Codexis."

Codexis, Inc. is a leading provider of optimized biocatalysts that make existing industrial processes faster, cleaner and more efficient than current methods and have the potential to make new industrial processes possible at commercial scale.  Codexis has commercialized its biocatalysts in the pharmaceutical industry and is developing biocatalysts for use in producing advanced biofuels under a multi-year research and development collaboration. The company is also using its technology platform to pursue biocatalyst-enabled solutions in other bioindustrial markets, including carbon management, water treatment and chemicals. 

Contact: Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212-827-3771.

SOURCE Codexis, Inc.

Back to top

RELATED LINKS
http://www.codexis.com

'/>"/>

SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis Appoints Singapore Laboratories Managing Director
2. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
3. Bruce Pasternack Elected to Codexis Board
4. Codexis Opens Singapore Laboratory
5. Rothwell, Wolf Elected to Codexis Board
6. Codexis Launches Codex(TM) MicroCyp Platform to Produce Drug Metabolites and Novel Lead Compounds
7. Codexis Names David Anton VP Bioindustrials R&D
8. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
9. Codexis, Arch Announce Expanded Collaboration
10. Codexis Names Vice President, Intellectual Property
11. Codexis, Teva in Licensing Agreement Final
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):